Editor of New England Journal of Medicine defends catastrophic experiments, and the Institute of Medicine expands prison drug trials. Question: How many times have these members of the elite put their own life at risk “to advance our knowledge?”Read More
Hepatitis B is a serious disease. It is highly prevalent in many countries in Asia (nearly 10% of Chinese carried the illness in 1992). Fortunately its prevalence in the US is very low. According to CDC data, the overall reported US incidence rate for 2013 was 1.0 case of hepatitis B per 100,000 population. After adjusting…Read More
Institute of Medicine report called the pattern of higher rates of disease and shorter lives “the U.S. health disadvantage,” and said it was responsible for dragging the country to the bottom in terms of life expectancy over the past 30 years.Read More
FDA’s preeminent authority to determine whether a drug or device is approved is its assumed scientific expertise and honest, independent review of safety and performance data from scientifically valid, controlled clinical trials. However, surveys of FDA scientists and numerous independent investigations by highly credible entities have all confirmed serious deficiencies in FDA’s scientific base and…Read More
Since 1995 FDA scientists have been at odds against FDA managers who routinely override sientists’ safety concerns to approve dubious prescription drugs.
Since 1995 FDA scientists have been at odds against FDA managers who routinely override sientists’ safety concerns to approve dubious prescription drugs.Read More